Predictive oncology investor alert by the former attorney general of louisiana: kahn swick & foti, llc investigates adequacy of price and process in proposed sale of predictive oncology inc. - poai

New orleans, aug. 19, 2025 (globe newswire) -- former attorney general of louisiana charles c. foti, jr., esq. and the law firm of kahn swick & foti, llc (“ksf”) are investigating the proposed sale of predictive oncology inc. (nasdaqcm: poai) to renovaro inc. (nasdaqcm: renb). under the terms of the binding letter of intent, predictive oncology will be merged into renovaro in exchange for a newly created series of preferred stock of renovaro. the preferred stock will be issued to shareholders of predictive oncology in a 1:1 exchange for their existing predictive oncology common stock. ksf is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the company.
POAI Ratings Summary
POAI Quant Ranking